Smith & Nephew SNATSvsThermo Fisher Scientific

SNN and TMO stock compared: price, dividend, valuation and results, from SEC filings.

SNN

Smith & Nephew SNATS, Inc.

$29.83

Value –

+0.00%
SNN's page

TMO

Thermo Fisher Scientific Inc

$669.54

Value $249B

-2.79%
TMO's page

Over the last year, with dividends, SNN moved -5.1% and TMO +17.1%. Dividend yield: SNN none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    SNN–

    TMO$249B

  • Revenue, 12 months

    SNN$6.2B

    TMO$47.4B

    TMO is 7.7 times SNN

  • Net income, 12 months

    SNN$625M

    TMO$7.1B

    TMO is 11 times SNN

  • Operating margin

    SNN12.9%

    TMO17.9%

    5.0 points apart

  • ROIC

    SNN7.4%

    TMO8.2%

    0.8 points apart

  • P/E

    SNN–

    TMO35.2

  • Dividend yield

    SNN0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    SNN-1.4%

    TMO+6.8%

    8.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

SNN-1.4%

TMO+6.8%

608010012020222023202420252026
Returns by period
PeriodSNNWith dividendsTMOWith dividends
1 year since November 19, 2025-5.1%Price -7.6%+17.1%Price +16.7%
3 years since November 20, 2023+26.3%+8.1% a yearPrice +16.7%+44.1%+13.0% a yearPrice +42.7%
5 years since November 19, 2021-1.4%-0.3% a yearPrice -13.9%+6.8%+1.3% a yearPrice +5.3%
10 years since November 21, 2016+34.7%+3.0% a yearPrice +6.8%+371.2%+16.8% a yearPrice +358.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

SNNSmith & Nephew SNATSTMOThermo Fisher Scientific

Valuation

SNNTMO
Valuation
Price$29.83$669.54
Market value–$249B
Enterprise value (EV)–$284B
P/E–35.2
P/E, 5-year median55.132.7
P/B–4.5
EV/EBIT–33.5
Free cash flow yield–3.1%

Results and growth

SNNTMO
Results and growth
Revenue, 12 months$6.2B$47.4B
Net income, 12 months$625M$7.1B
Free cash flow, 12 months$852M$7.6B
Earnings per share, 12 months$0.72$18.96
Revenue growth, year on year6.1%3.9%
Revenue growth a year, past+6.2%over 5 years+6.7%over 5 years
EPS growth a year, past-57.4%over 5 years+2.1%over 5 years

Margins and returns on capital

SNNTMO
Margins and returns on capital
Gross margin68.0%–
Operating margin12.9%17.9%
Net margin10.1%14.9%
ROIC7.4%8.2%
ROE11.8%13.4%

Balance sheet

SNNTMO
Balance sheet
Cash$557M$6.1B
Total debt$3.4B$41.4B
Net debt / EBITDA–3.7
Interest cover5.7×5.5×

Dividends and buybacks

SNNTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months$0.38$1.84
Dividend growth a year, past+0.2%over 5 years+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: SNN or TMO

Didn't find what you were looking for?

Ask us
How did SNN and TMO stock do over the last 10 years?

Since November 21, 2016, SNN's price moved +6.8% and TMO's +358.1%. With dividends: SNN +34.7% (+3.0% a year), TMO +371.2% (+16.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, SNN or TMO?

The dividend yield at today's price is none for Smith & Nephew SNATS and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid $0.38 and $1.84 per share.

Which has the higher profit margins, Smith & Nephew SNATS or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 10.1% for Smith & Nephew SNATS and 14.9% for Thermo Fisher Scientific, and the operating margin 12.9% and 17.9%. Revenue was $6.2B and $47.4B.

Which is the better investment, Smith & Nephew SNATS or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.